PANOPTES PHARMA

Panoptes is a privately held biotech company focused on developing small molecule based therapies for the treatment of severe eye diseases with high unmet medical need. Panoptes is located in the city center of Vienna, Austria. The development of Panoptes´ clinical candidate PP-001 focuses on a new treatment for autoimmune uveitis, a disease which is one of the major causes of blindness. As a second indication, adenoviral conjunctivitis will be pursued, a disease for which to date, no treatmen... t is available. Due to its unique mode of action, PP-001 has therapeutic potential for additional inflammatory and viral indications. Panoptes has an experienced team of development experts with a proven track record of developing and commercializing innovative products. The team is developing a focused portfolio of high-performance small molecule products, with its lead clinical candidate PP-001 in preclinical development.

#People #Financial #Website #More

PANOPTES PHARMA

Social Links:

Industry:

Biotechnology Health Care

Founded:

2013-01-01

Address:

Vienna, Wien, Austria

Country:

Austria

Website Url:

http://www.panoptes-pharma.com

Total Employee:

Status:

Active

Contact:

43 676 644 7510

Email Addresses:

[email protected]

Total Funding:

Technology used in webpage:

Euro IPv6 1and1

Founder

franz-obermayr_image

Franz Obermayr

stefan-sperl_image

Stefan Sperl

Investors List

aws-grnderfonds_image

Official Site Inspections

http://www.panoptes-pharma.com

Host Informations
Whois Informations

Loading ...